medical condition treated by semaglutide Wegovy® – A New Treatment for Obesity Is Your Med Spa 'Ozempic'

Sikiric P, Drmic D, Sever M, Klicek R, Blagaic AB, Tvrdeic A, et al

If Rybelsus is not providing adequate symptom control or is causing problematic side effects, your healthcare team can discuss alternative GLP-1 receptor agonists or other glucose-lowering therapies that may be better suited to your needs

Diabetic wound healing studies demonstrate enhanced outcomes even under compromised metabolic conditions

When Ozempic received FDA approval in December 2017, its labeling mentioned only mild gastrointestinal side effects like nausea and vomiting common and generally temporary reactions to GLP-1 medications

DOI: 10.2337/dc22-0123 Bianchi, F., Lupo, R., & Ferraro, A

Motion's adaptive goals adjust based on a 12-week rolling average of your actual activity